Ds Healthcare Group, Inc. Receivables Turnover Ratio (DSKX), from the second quarter 2017 to the second quarter 2016 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Ds Healthcare Group, Inc.  (DSKX)
 

Ds Healthcare Group Accounts Receivables Turnover Ratio from the second quarter 2017 to the second quarter 2016

Quarterly Results, Trends, Rankings, Statistics


Ds Healthcare Group, Inc.'s ability to collect accounts receivable sequentially worsen to 4.54, pointing to a challenging and on top of that deteriorating business climate for the Biotechnology & Pharmaceuticals industry. Ds Healthcare Group's Accounts Receivable average collection period in the Jun 30 2017 quarter, has increased to 80 days, from 60 days, in the Mar 31 2017 quarter.

If we take a look into Healthcare sector 109 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2017 from 317 to 1358.

What is Receivable Turnover Ratio?
What is Ds Healthcare Group, Inc. Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

DSKX Receivables Turnover Ratio (Jun 30 2017)
II. Quarter		 (Mar 31 2017)
I. Quarter		 (Dec 31 2016)
IV. Quarter		 (Sep 30 2016)
III. Quarter		 (Jun 30 2016)
II. Quarter
Y / Y Receivable Change -6.82 % -29.94 % 62.2 % -58.38 % -17.44 %
Y / Y Revenue Change -53.97 % -9.92 % - -14.23 % 46.62 %
Receivable Turnover Ratio (TTM) 4.54 6.13 5.95 8.49 6.63
DSKX's Total Ranking # 1358 # 317 # 310 # 1795 #
Accounts Receivable average collection period days 80 60 61 43 55
Seq. Receivable Change 85.14 % -67.88 % 91.29 % -18.08 % 39.2 %
Seq. Revenue Change 6.48 % - - -44.78 % 108.38 %


Receivable Turnover Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 9
Healthcare Sector # 110
Overall Market # 1358

Receivable Turnover Ratio Statistics
High Average Low
9.74 6.72 5.2
(Mar 31 2017)   (Dec 31 2012)





DSKX Company Profile • Back to DSKX Efficiency Comparisons • Compare DSKX Receivables Turnover Ratio to its Competitors

Financial Statements
Ds Healthcare Group's Accounts Receivable $ 2 Millions Visit DSKX's Balance sheet
Ds Healthcare Group's Sales TTM $ 7 Millions Visit DSKX's Income Statement
Sources of DSKX's Revenues Visit DSKX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
DSKX's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
DSKX's Growth Rates DSKX's Roa DSKX's Inventory Turnover Ratio DSKX's Dividend Comparisons
DSKX's Profitability Ratios DSKX's Roi DSKX's Asset Turnover Ratio DSKX's Dividend Growth
DSKX's Valuation Ratios DSKX's Roe DSKX's Financial Strength Ratios DSKX's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2017, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 30 2017 Receivable at quarter ending Jun 30 2017
Cv Sciences Inc   12.64 $ 13.274  Millions$ 1.050  Millions
Viskase Holdings inc   12.63 $ 11.054  Millions$ 0.875  Millions
Integrated Biopharma Inc  12.60 $ 46.954  Millions$ 3.728  Millions
Kineta Inc   12.44 $ 7.943  Millions$ 0.638  Millions
International Stem Cell Corporation  12.39 $ 7.400  Millions$ 0.597  Millions
Tearlab Corp  12.36 $ 28.059  Millions$ 2.270  Millions
Clearday Inc   12.31 $ 0.040  Millions$ 0.003  Millions
Exact Sciences Corporation  12.27 $ 169.365  Millions$ 13.799  Millions
Cas Medical Systems Inc  12.24 $ 21.040  Millions$ 1.720  Millions
Fortress Biotech Inc   12.13 $ 64.466  Millions$ 5.314  Millions
Intelgenx Technologies Corp   12.12 $ 6.209  Millions$ 0.513  Millions
Dmk Pharmaceuticals Corporation  12.00 $ 11.389  Millions$ 0.949  Millions
Kadmon holdings inc   11.84 $ 18.495  Millions$ 1.563  Millions
Otonomy Inc   11.83 $ 1.278  Millions$ 0.108  Millions
Corcept Therapeutics Inc  11.81 $ 108.694  Millions$ 9.204  Millions
Oncomed Pharmaceuticals Inc  11.68 $ 24.546  Millions$ 2.101  Millions
National Healthcare Corp  11.50 $ 947.982  Millions$ 82.462  Millions
Avid Bioservices Inc   11.47 $ 79.098  Millions$ 6.894  Millions
Edesa Biotech Inc   11.37 $ 0.502  Millions$ 0.044  Millions
Dariohealth Corp   11.30 $ 3.783  Millions$ 0.335  Millions
Insulet Corporation  11.25 $ 409.915  Millions$ 36.438  Millions
Teladoc Health Inc   11.18 $ 157.270  Millions$ 14.062  Millions
Immucell Corporation  11.08 $ 9.379  Millions$ 0.847  Millions
Corbus Pharmaceuticals Holdings Inc   11.05 $ 2.762  Millions$ 0.250  Millions
Durect Corp  11.01 $ 16.146  Millions$ 1.466  Millions
Lifeloc Technologies Inc   10.70 $ 7.905  Millions$ 0.738  Millions
Mymetics Corporation  10.61 $ 1.225  Millions$ 0.116  Millions
Inotiv Inc   10.60 $ 23.523  Millions$ 2.220  Millions
Aptevo Therapeutics Inc   10.47 $ 36.347  Millions$ 3.471  Millions
Chinook Therapeutics Inc   10.40 $ 17.361  Millions$ 1.669  Millions

Date modified: 2026-06-22T14:32:03+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.